| Contact Details | Suite 408, Gasan digital 1-Ro 58, Geumcheon-gu, Seoul +82-2-2071-3310 |
|---|
Eutilex
Category:
Venture
Main Business Area
The core technology that the Eutilex employs for drug development is selecting targets that faithfully enhance or suppress human immune responses. A series of immunomodulatory antibody therapeutics have been developed on that principle to treat cancers and autoimmune diseases.
